Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

Time-restricted Feeding Changes as Inspiration for Drug Design

Author(s): Zhangyuting He, Huayu Yang and Yilei Mao*

Volume 29, Issue 8, 2023

Published on: 28 March, 2023

Page: [559 - 561] Pages: 3

DOI: 10.2174/1381612829666230307104103

Abstract

Time-restricted feeding (TRF) is a special lifestyle intervention that improves glucose metabolism, regulates lipid metabolism, increases gut micro richness, and strengthens circadian rhythm. Diabetes is a remarkable component of metabolic syndrome, and individuals with diabetes can benefit from TRF. Melatonin and agomelatine can strengthen circadian rhythm, which is a crucial mechanism of TRF. New drug designs can be inspired by the related mechanisms and influences of TRF on glucose metabolism, and more researches are needed to clarify the specific diet-related mechanisms and apply this knowledge to further drug design.

Keywords: Drug design, glucose metabolism, metabolic syndrome, time-restricted feeding, melatonin, agomelatine.

« Previous Next »
[1]
Świątkiewicz I, Woźniak A, Taub PR. Time-restricted eating and metabolic syndrome: Current status and future perspectives. Nutrients 2021; 13(1): 221.
[http://dx.doi.org/10.3390/nu13010221] [PMID: 33466692]
[2]
Xie Z, Sun Y, Ye Y, et al. Randomized controlled trial for time-restricted eating in healthy volunteers without obesity. Nat Commun 2022; 13(1): 1003.
[http://dx.doi.org/10.1038/s41467-022-28662-5] [PMID: 35194047]
[3]
Mantovani A, Lombardi R, Dalbeni A. Glucose-lowering agents and reduced risk of incident non-alcoholic fatty liver disease: New insights. Hepatobiliary Surg Nutr 2022; 11(1): 156-60.
[http://dx.doi.org/10.21037/hbsn-2021-28] [PMID: 35284515]
[4]
Shimada S, Kamiyama T, Orimo T, Nagatsu A, Kamachi H, Taketomi A. High HbA1c is a risk factor for complications after hepatectomy and influences for hepatocellular carcinoma without HBV and HCV infection. Hepatobiliary Surg Nutr 2021; 10(4): 454-63.
[http://dx.doi.org/10.21037/hbsn.2020.01.03] [PMID: 34430524]
[5]
Mantovani A, Targher G. Glucagon-like peptide-1 receptor agonists for treatment of nonalcoholic steatohepatitis: New insights from subcutaneous semaglutide. Hepatobiliary Surg Nutr 2021; 10(4): 518-21.
[http://dx.doi.org/10.21037/hbsn-2021-13] [PMID: 34430533]
[6]
Jamshed H, Beyl R, Della Manna D, Yang E, Ravussin E, Peterson C. Early time-restricted feeding improves 24-hour glucose levels and affects markers of the circadian clock, aging, and autophagy in humans. Nutrients 2019; 11(6): 1234.
[http://dx.doi.org/10.3390/nu11061234] [PMID: 31151228]
[7]
Xie Z, He Z, Ye Y, Mao Y. Effects of time-restricted feeding with different feeding windows on metabolic health: A systematic review of human studies. Nutrition 2022; 102: 111764.
[http://dx.doi.org/10.1016/j.nut.2022.111764] [PMID: 35820237]
[8]
Cienfuegos S, McStay M, Gabel K, Varady KA. Time restricted eating for the prevention of type 2 diabetes. J Physiol 2022; 600(5): 1253-64.
[http://dx.doi.org/10.1113/JP281101] [PMID: 34418079]
[9]
Zeb F, Wu X, Chen L, et al. Effect of time-restricted feeding on metabolic risk and circadian rhythm associated with gut microbiome in healthy males. Br J Nutr 2020; 123(11): 1216-26.
[http://dx.doi.org/10.1017/S0007114519003428] [PMID: 31902372]
[10]
Kim BH, Joo Y, Kim MS, Choe HK, Tong Q, Kwon O. Effects of intermittent fasting on the circulating levels and circadian rhythms of hormones. Endocrinol Metab 2021; 36(4): 745-56.
[http://dx.doi.org/10.3803/EnM.2021.405] [PMID: 34474513]
[11]
Poggiogalle E, Jamshed H, Peterson CM. Circadian regulation of glucose, lipid, and energy metabolism in humans. Metabolism 2018; 84: 11-27.
[http://dx.doi.org/10.1016/j.metabol.2017.11.017] [PMID: 29195759]
[12]
Chawla S, Beretoulis S, Deere A, Radenkovic D. The window matters: A systematic review of time restricted eating strategies in relation to cortisol and melatonin secretion. Nutrients 2021; 13(8): 2525.
[http://dx.doi.org/10.3390/nu13082525] [PMID: 34444685]
[13]
Lauritzen ES, Kampmann U, Smedegaard SB, Støy J. Effects of daily administration of melatonin before bedtime on fasting insulin, glucose and insulin sensitivity in healthy adults and patients with metabolic diseases. A systematic review and meta‐analysis. Clin Endocrinol 2021; 95(5): 691-701.
[http://dx.doi.org/10.1111/cen.14576] [PMID: 34370338]
[14]
Diez-Echave P, Vezza T, Algieri F, et al. The melatonergic agonist agomelatine ameliorates high fat diet-induced obesity in mice through the modulation of the gut microbiome. Biomed Pharmacother 2022; 153: 113445.
[http://dx.doi.org/10.1016/j.biopha.2022.113445] [PMID: 36076560]
[15]
Che T, Teng X, Huang Q, et al. Agomelatine versus fluoxetine in glycemic control and treating depressive and anxiety symptoms in type 2 diabetes mellitus subjects: A single-blind randomized controlled trial. Neuropsychiatr Dis Treat 2018; 14: 1527-33.
[http://dx.doi.org/10.2147/NDT.S167608] [PMID: 29942131]

Rights & Permissions Print Cite
Article Metrics
24
2
© 2024 Bentham Science Publishers | Privacy Policy